Heidi Hunter - 30 May 2025 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role: Director
Signature: /s/ Brian Burkavage, Attorney-in-Fact for Heidi Hunter
Issuer symbol: IOBT
Transactions as of: 30 May 2025
Net transactions value: +$20,884
Form type: 4
Filing time: 02 Jun 2025, 07:53:36 UTC
Previous filing: 10 Jun 2024
Next filing: 06 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hunter Heidi	Director	C/O IO BIOTECH, INC., OLE MAALOES VEJ 3, COPENHAGEN, DENMARK	/s/ Brian Burkavage, Attorney-in-Fact for Heidi Hunter	02 Jun 2025	0001891841

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IOBT	Common Stock	Purchase	$20,884	+15,000		$1.39	15,000	30 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction was executed in multiple trades in prices ranging from $1.37 to $1.40, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The transaction was executed in multiple trades in prices ranging from $1.37 to $1.40, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.